Related Experiment Video
Updated: Mar 7, 2026

Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis
Published on: February 6, 2021
Clinical Features and Management of Subretinal Abscesses Secondary to Methicillin-Resistant Staphylococcus aureus
Background And Objective:
To describe the clinical features, management, and immediate outcomes of patients with subretinal abscesses secondary to methicillin-resistant Staphylococcus aureus (MRSA) endogenous endophthalmitis.
Patients And Methods:
Eleven eyes of seven patients were identified by retrospective chart review. Demographics, initial presentation, examination findings, imaging, cultures, treatments, and short-term outcomes were reviewed.
Results:
Eleven eyes of seven patients presented with subretinal abscesses secondary to MRSA endogenous endophthalmitis. Four had history of recurrent MRSA infections or active soft-tissue ulceration. Six underwent vitreous tap for culture without growth. Three had positive blood cultures for MRSA. Six received empiric therapy with intravenous vancomycin, one received oral trimethoprim-sulfamethoxazole, and six received intravitreal vancomycin. Consolidation of abscesses was seen within days of initial treatment. Visual outcomes were contingent on abscess location and time to initial treatment.
Conclusion:
Prompt diagnosis and systemic antibiotic therapy is paramount in the treatment of this rare presentation. [Ophthalmic Surg Lasers Imaging Retina. 2017;48:134-142.].
Insights
Prompt diagnosis and systemic antibiotic therapy are crucial for treating subretinal abscesses caused by methicillin-resistant Staphylococcus aureus (MRSA) endogenous endophthalmitis, leading to abscess consolidation.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Microbiology
Background:
- Investigating subretinal abscesses as a rare manifestation of endogenous endophthalmitis.
- Focusing on cases caused by methicillin-resistant Staphylococcus aureus (MRSA).
Observation:
- Retrospective review of eleven eyes from seven patients with MRSA endogenous endophthalmitis.
- Noting a history of recurrent MRSA infections or active skin ulcerations in some patients.
- Vitreous and blood cultures were analyzed for MRSA identification.
Findings:
- Subretinal abscesses were observed in eleven eyes secondary to MRSA endogenous endophthalmitis.
- Systemic and intravitreal vancomycin were primary treatment modalities.
- Abscess consolidation occurred rapidly following initiation of antibiotic therapy.
- Visual outcomes depended on abscess location and treatment timeliness.
Implications:
- Highlights the importance of prompt diagnosis and systemic antibiotic treatment for this condition.
- Emphasizes the role of vancomycin in managing MRSA endophthalmitis.
- Suggests that early intervention improves visual prognosis in subretinal abscesses.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
Endocarditis III: Medical Management
Endocarditis I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management

